• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    XWELL Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    1/7/25 9:10:24 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary
    Get the next $XWEL alert in real time by email
    false 0001410428 0001410428 2025-01-02 2025-01-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(D) of the Securities Exchange Act Of 1934

     

    Date of report (Date of earliest event reported): January 2, 2025

     

    XWELL, Inc.

    (Exact Name of Registrant as Specified in Its Charter)

     

    Delaware

    (State or Other Jurisdiction of Incorporation)

     

    001-34785   20-4988129
    (Commission File Number)   (IRS Employer Identification No.)

     

    254 West 31st Street, 11th Floor, New York, New York   10001
    (Address of Principal Executive Offices)   (Zip Code)

     

    (212) 750-9595

    (Registrant’s Telephone Number, Including Area Code)

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.01 per share   XWEL   The Nasdaq Stock Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨ 

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 

     

     

     

     

     

     

    Item 5.02Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

     

    Resignation, Separation Agreement and Release with Suzanne Scrabis

     

    On January 2, 2025, XWELL, Inc. (the “Company”) entered into that certain Resignation, Separation Agreement and Release (the “Scrabis Release Agreement”), by and between the Company and Suzanne Scrabis, and effective as January 8, 2025 (the “Scrabis Separation Date”), in connection with Ms. Scrabis’s resignation as the Chief Financial Officer of the Company. Pursuant to the terms of the Scrabis Release Agreement, in consideration for performing certain transition services and entering into the Scrabis Release Agreement, Ms. Scrabis will receive within 30 days from the Separation Date, a regular bi-weekly salary in the amount of $11,538.46 for a period of six months, less all applicable deductions and withholdings. The Company has additionally agreed to reimburse the portion of Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, premiums paid by Ms. Scrabis for the continuation of health coverage under the Company’s group benefit plans, for up to six months and subject to certain exceptions.

     

    The Scrabis Release Agreement also provides for certain customary covenants regarding confidentiality and a release of claims. Ms. Scrabis’s resignation as the Chief Financial Officer of the Company was not the result of any disagreement regarding any matter relating to the Company’s operations, policies, or practices.

     

    Executive Employment Agreement with Thomas Ian Brown

     

    On January 3, 2025, the Company entered into that certain Executive Employment Agreement (the “Brown Employment Agreement”) with Thomas Ian Brown, effective as of January 6, 2025 (the “Brown Effective Date”). As of the Brown Effective Date, Mr. Brown shall serve as the Company’s Chief Financial Officer.

     

    Pursuant to the terms of the Brown Employment Agreement, Mr. Brown shall be employed for a period of three years beginning on the Brown Effective Date (the “Initial Employment Period”), which such period shall be automatically renewed for additional consecutive terms of one year each (each, a “Renewal Period” and together with the Initial Employment Period, the “Employment Period”), unless either Mr. Brown or the Company provide a written notice of non-renewal at least 30 days prior to the end of the Initial Employment Period or the then-current Renewal Period, as applicable. The Company shall pay Mr. Brown an annual base salary of $375,000 (the “Base Salary”), less applicable taxes and deductions. Mr. Brown will additionally receive (i) a signing bonus in the amount of $75,000 and (ii) a guaranteed bonus of $75,000 within 30 days of the first anniversary of the Brown Effective Date, provided that Mr. Brown has been an employee in good standing at all times throughout such period. During the Employment Period, Mr. Brown will be eligible to earn an annual bonus of up to 100% of the Base Salary, based upon the achievement of performance goals and metrics established by the Board at its sole discretion, which such bonus payment, if any, shall be split 50/50 between cash and a grant of restricted stock units with respect to the Company’s common stock, par value $0.01 per share (the “Common Stock”). Additionally, following the Brown Effective Date, Mr. Brown shall be granted (A) stock options to purchase up to 37,000 shares of Common Stock at an exercise price equal to the fair market value on the date of the grant, which shall be the closing price of the grant date, with such stock options to vest in four quarterly installments of 25% each on the first, second, third and fourth quarters after the grant date.

     

    Pursuant to the terms of the Brown Employment Agreement, the Company may terminate the Brown Employment Agreement and Mr. Brown’s employment thereunder for Cause or Good Reason (as such terms are defined in the Brown Employment Agreement) at any time during the Employment Period and pursuant to the terms and conditions of the Brown Employment Agreement, or without Cause or Good Reason at any time during the Employment Period and pursuant to the terms and conditions of the Brown Employment Agreement.

     

    Ian Brown has more than 25 years of experience in operational finance. He has expertise in systems transformation, financial operations, and back-office process improvement. From 2022 to 2025, Mr. Brown was a Managing Director of the Strategic FP&A Group at Accordion. Prior to that role, he served at FTI Consulting in their Technology Transformation group from 2014 to 2022. Prior, he was Senior Director Business Planning, Customer Operations at Charter Communications, and a Director of Operational Finance for Insight Communications. Before this, Ian was the CFO of two early-stage companies, was a colleague of Ezra Ernst at Wolters Kluwer, and also worked in media investment banking. He holds an M.B.A from The Tuck School of Business at Dartmouth and a B.A. from Vassar College.

     

    There is no family relationship between Mr. Brown and any director or executive officer of the Company. There are no transactions between Mr. Brown and the Company that would be required to be reported under Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.

     

     

     

     

    The foregoing is only a summary of the material terms of the Scrabis Release Agreement and the Brown Employment Agreement and does not purport to be complete. The foregoing summary is qualified in its entirety by reference to the complete text of the Scrabis Release Agreement and the Brown Employment Agreement, which are attached hereto as Exhibits 10.1 and 10.2, respectively, and incorporated herein by reference.

     

    Item 7.01Regulation FD Disclosure

     

    On January 7, 2025, the Company issued a press release announcing the change in the Company’s management, attached hereto as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto.

     

    The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished pursuant to Item 7.01 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing.

     

    Forward-Looking Statements

     

    The press release includes forward-looking statements, which may be identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” or the negative of such terms, or other comparable terminology. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained herein. The forward-looking statements in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including, but not limited to, the risks and uncertainties and other factors discussed from time to time in the Company’s filings with the SEC, including the Company’s Annual Report on Form 10-K, as amended, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and proxy statements, registration statement and other documents filed by the Company from time to time with the SEC. The Company expressly disclaims any obligation to publicly update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

     

    Item 9.01Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit
    No.
      Description
         
    10.1   Resignation, Separation Agreement and Release with Suzanne A. Scrabis, effective as of January 8, 2025
    10.2   Executive Employment Agreement with Thomas Ian Brown, effective as of January 6, 2025
    99.1   Press Release, dated January 7, 2025
    104   Cover Page Interactive Data File (formatted as Inline XBRL)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      XWELL, Inc.
         
    Date: January 7, 2025 By: /s/ Ezra T. Ernst
      Name: Ezra T. Ernst
      Title: President and Chief Executive Officer

     

     

     

    Get the next $XWEL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XWEL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XWEL
    SEC Filings

    View All

    XWELL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - XWELL, Inc. (0001410428) (Filer)

    3/4/26 5:19:22 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - XWELL, Inc. (0001410428) (Filer)

    2/25/26 8:49:45 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - XWELL, Inc. (0001410428) (Filer)

    12/18/25 4:37:15 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weinstein Robert was granted 100,000 shares, increasing direct ownership by 87% to 215,231 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:45:36 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Lebowitz Michael was granted 100,000 shares, increasing direct ownership by 90% to 211,122 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:43:54 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    President and CEO Ernst Ezra was granted 100,000 shares, increasing direct ownership by 99% to 201,130 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:43:16 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wizenberg Gaelle Sandra bought $1,987 worth of shares (1,201 units at $1.65), increasing direct ownership by 402% to 1,500 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    9/13/24 5:41:59 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Wizenberg Gaelle Sandra bought $551 worth of shares (299 units at $1.84) (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    7/22/24 8:47:43 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone

    DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning's tape highlights companies positioning for scale in 2026 and beyond. Totaligent Targets APAC Biologics and Medical Tourism Totaligent (OTCID: TGNT) announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent's recently announced Aetherium Medical platform. The agreement e

    2/25/26 9:38:05 AM ET
    $NXPL
    $RXRX
    $XWEL
    Telecommunications Equipment
    Telecommunications
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses. The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible into an aggregate of 66,666,669 shares of common stock of the Company at an initial con

    2/24/26 4:15:00 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone

    NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (NASDAQ:XWEL), a provider of wellness and biosecurity solutions, today announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention (CDC). The announcement follows a recent CDC milestone for the Traveler-based Genomic Surveillance (TGS) program — part of the Biothreat Radar Detection System — which has surpassed one million voluntary participants with XWELL and Ginkgo Biosecurity. Building on this milestone, the collaboration embeds AI-driven forecasting directly into frontline biosecuri

    2/3/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Leadership Updates

    Live Leadership Updates

    View All

    XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced today that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance (TGS) program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on t

    1/8/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Expands Florida Presence with Grand Opening of Waterford Lakes Wellness Center on September 5

    ORLANDO, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- XWELL (NASDAQ:XWEL) ("XWELL" or the "Company"), a leader in wellness solutions for people on the go, is pleased to announce the grand opening of its newest Florida wellness center at Orlando's Waterford Lakes Town Center on Thursday, September 5. The celebration will feature live demonstrations, skincare consultations, and special participation from the Orlando Magic, which recently named XWELL its official wellness spa. You're Invited: Celebrate with UsGuests are invited to join XWELL for an official ribbon-cutting and a first look at the Orlando area's newest destination for self-care: Date: Thursday, September 5Time: 3:00 PM – 7:00 PM E

    8/28/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Launches All-New Website, Offering Seamless Booking and Unified Access to Health, Wellness & Beauty Services

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL), a leading provider of wellness solutions for people on the go, today unveiled its newly redesigned website — a digital destination that integrates all of the company's services and offerings, allowing customers to discover, book, and engage through a seamless, user-first experience. Accessible at xwell.com, the updated platform unites XWELL's health, wellness, and beauty brands — Xpres Spa®, Naples Wax Center®, XpresCheck®, and HyperPointe™ — under one cohesive experience. Visitors can now explore locations, connect with spa staff, and book services, all in a few clicks. "This new website is a reflection of where XWEL

    7/29/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Financials

    Live finance-specific insights

    View All

    XWELL Reports Second Quarter 2025 Results

    NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing critical biosecurity support to building tech-forward wellness spaces in transportation hubs and local communities, XWELL currently is on a growth trajectory. Through its portfolio of in-airport and off-airport brands, the Company is reimagining what it means to access wellness. Operating Highlights Revenue for the 2025 second quarter totaled $7.7 millionCost of sales decreased approximately 5% from the 2024 second quarterGeneral and administrativ

    8/14/25 4:30:31 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025

    NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced that it will report second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast, as there is a limited capacity to access the conference call by dialing 1-412-317-6026. The live and later archived webcast can be accessed from the Investor Relations section of the Company's website at https://www.xwell.com. Visitors to the

    8/13/25 4:30:42 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness

    NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport and off-airport wellness brands, XWELL continues to redefine what wellness access looks like --connecting high-impact, science-backed care to everyday consumers wherever they are. From leading the nation's biosecurity response to building tech-forward wellness spaces in transportation hubs and neighborhoods alike, XWELL is extending wellness beyond the elite and into real life. Operating Highlights: Reported first quarter 2025 revenue of $

    5/20/25 4:15:18 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    8/13/24 5:18:44 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by XWELL Inc.

    SC 13G - XWELL, Inc. (0001410428) (Subject)

    8/9/24 4:05:23 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    7/22/24 6:11:01 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary